Most of these miRNAs repressed cancer cell EMT and metastasis in most examined cancer types, and some of them (miR-33a and miR-186) modulated cancer cell sensitivity to cisplatin by down-regulating TWIST1 [27, 30]. The gene discussed is TWIST1; the disease is cancer.